[{"id":"d7c95ee1-956c-45c4-a831-43623a7594bf","acronym":"","url":"https://clinicaltrials.gov/study/NCT03556982","created_at":"2021-01-18T17:30:30.309Z","updated_at":"2024-07-02T16:37:10.067Z","phase":"Phase 1/2","brief_title":"CART-123 FOR Relapsed/Refractory Acute Myelocytic Leukemia（AML）","source_id_and_acronym":"NCT03556982","lead_sponsor":"The Affiliated Hospital of the Chinese Academy of Military Medical Sciences","biomarkers":" CD123 • IL3RA","pipe":" | ","alterations":" CD123 expression • IL3RA expression","tags":["CD123 • IL3RA"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CD123 expression • IL3RA expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CTL123"],"overall_status":"Unknown status","enrollment":" Enrollment 10","initiation":"Initiation: 03/01/2018","start_date":" 03/01/2018","primary_txt":" Primary completion: 03/01/2019","primary_completion_date":" 03/01/2019","study_txt":" Completion: 03/01/2020","study_completion_date":" 03/01/2020","last_update_posted":"2018-06-14"}]